CSE:NOVO-B.CO 20 November 2025 - 2 February 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.

Novo Nordisk stock slides as broker cuts rating ahead of Feb. 4 earnings

Novo Nordisk shares dipped Monday following a broker downgrade just before this week’s earnings, adding to the Danish drugmaker’s stock pressure in early February trading.

2 February 2026

CSE:NOVO-B.CO·Earnings Reports·Pharmaceutical Industry·Stock Market

Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Stock Today (November 20, 2025): Wegovy Price Cuts, Alzheimer’s ‘Lottery Ticket’ Trials and Denmark GDP Put NVO Back in the Spotlight

Novo Nordisk stock is back on traders’ screens today as a cluster of fresh headlines – from high‑stakes Alzheimer’s trials to aggressive Wegovy price cuts and new Danish GDP data – reshapes the narrative around the Ozempic maker.

20 November 2025

CSE:NOVO-B.CO·NYSE:NVO·Pharmaceuticals·Stock Market

Go toTop